About Shield Therapeutics

Shield Therapeutics develops pharmaceutical solutions for people living with iron deficiency and iron deficiency anaemia. The company's lead product, ACCRUFeR (ferric maltol), is a prescription oral iron treatment offering patients a safe, effective alternative to intravenous therapy. As America's leading branded oral iron, it serves patients who need reliable treatment without hospital visits. The company operates globally with regulatory approvals expanding across markets. Shield partners with healthcare providers to make evidence based oral iron therapy the standard of care, improving quality of life for patients who previously had limited options. Its success reflects clinical efficacy and commitment to addressing unmet needs.